ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth. Ma WK, Voss DM, Scharner J, Costa ASH, et al. Cancer Res 2021 Dec 17. pii: 0008-5472.CAN-20-0948.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma WK, Voss DM, Scharner J, Costa ASH, et al. ASO-based PKM splice-switching therapy inhibits hepatocellular carcinoma growth. Cancer Res 2021 Dec 17. pii: 0008-5472.CAN-20-0948.
PMID: 34921016